Integer (ITGR) to Release Earnings on Thursday

Integer (NYSE:ITGR) is expected to be issuing its Q4 2025 results before the market opens on Thursday, February 19th. Analysts expect Integer to post earnings of $1.70 per share and revenue of $462.7250 million for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 19, 2026 at 9:00 AM ET.

Integer Price Performance

NYSE:ITGR opened at $87.26 on Thursday. The company has a quick ratio of 2.45, a current ratio of 3.71 and a debt-to-equity ratio of 0.70. The business’s 50-day moving average price is $80.81 and its 200 day moving average price is $89.22. Integer has a 52-week low of $62.00 and a 52-week high of $144.76. The firm has a market cap of $3.06 billion, a P/E ratio of 36.51, a PEG ratio of 0.79 and a beta of 0.77.

Integer announced that its board has approved a stock repurchase plan on Tuesday, November 4th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to purchase up to 8.3% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s board of directors believes its shares are undervalued.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC raised its holdings in Integer by 210.5% during the second quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock worth $66,000 after purchasing an additional 362 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in shares of Integer by 861.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 692 shares of the medical equipment provider’s stock valued at $85,000 after purchasing an additional 620 shares during the period. State of Wyoming grew its stake in Integer by 434.2% during the 4th quarter. State of Wyoming now owns 1,608 shares of the medical equipment provider’s stock worth $126,000 after buying an additional 1,307 shares during the last quarter. Van ECK Associates Corp increased its position in Integer by 31.8% during the third quarter. Van ECK Associates Corp now owns 1,427 shares of the medical equipment provider’s stock worth $147,000 after buying an additional 344 shares during the period. Finally, Vident Advisory LLC acquired a new stake in shares of Integer in the second quarter valued at approximately $218,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ITGR. Raymond James Financial reaffirmed an “outperform” rating and issued a $95.00 price target (down previously from $143.00) on shares of Integer in a report on Friday, October 24th. Bank of America downgraded Integer from a “buy” rating to a “neutral” rating and set a $87.00 target price for the company. in a report on Friday, October 24th. Piper Sandler dropped their price target on Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Integer in a research note on Monday, December 29th. Finally, KeyCorp dropped their target price on shares of Integer from $145.00 to $133.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 21st. Four research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Integer has a consensus rating of “Hold” and a consensus target price of $98.38.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.